| 000 | 01318 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250512004255.0 | ||
| 264 | 0 | _c19890307 | |
| 008 | 198903s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOchoa, A C | |
| 245 | 0 | 0 |
_aLymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets. _h[electronic resource] |
| 260 |
_bCancer research _cFeb 1989 |
||
| 300 |
_a963-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 |
_aAntigens, Differentiation, T-Lymphocyte _ximmunology |
| 650 | 0 | 4 | _aCD3 Complex |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aCytotoxicity, Immunologic |
| 650 | 0 | 4 | _aFluorescent Antibody Technique |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-2 _ximmunology |
| 650 | 0 | 4 |
_aKiller Cells, Natural _xclassification |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _ximmunology |
| 650 | 0 | 4 |
_aRecombinant Proteins _ximmunology |
| 700 | 1 | _aHasz, D E | |
| 700 | 1 | _aRezonzew, R | |
| 700 | 1 | _aAnderson, P M | |
| 700 | 1 | _aBach, F H | |
| 773 | 0 |
_tCancer research _gvol. 49 _gno. 4 _gp. 963-8 |
|
| 999 |
_c2527431 _d2527431 |
||